|
American Association for Physician Leadership |
Improving Communication and Feedback in Health Care Leadership |
3.5 |
Yes |
6/30/2027 |
|
JAMA |
Improving Patient Comprehension Through Explanatory Communication |
1 |
Yes |
11/20/2027 |
|
American College of Medical Genetics and Genomics |
Improving Patient Safety: An Imperative in Medical Genetics and Genomics |
3 |
Yes |
12/4/2025 |
|
JAMA Pediatrics |
Incidence of Kawasaki Disease Before and After the COVID-19 Pandemic in Japan - Results of the 26th Nationwide Survey, 2019 to 2020 |
1 |
Yes |
10/26/2025 |
|
JAMA |
Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines |
1 |
Yes |
10/26/2025 |
|
JAMA Cardiology |
Incidental Complication From a Left Atrial Appendage Device |
1 |
Yes |
7/3/2027 |
|
JAMA Internal Medicine |
Incorrect Electrocardiogram Lead Placement in ST-Segment Elevation Myocardial Infarction |
1 |
Yes |
8/14/2026 |
|
American Medical Association |
Increasing Annual Prescription Renewal for Patients on Chronic Medications |
5 |
Yes |
12/15/2025 |
|
Massachusetts Medical Society |
Increasing HPV Vaccination Uptake in Massachusetts |
1 |
No |
7/16/2027 |
|
American Medical Association |
Indigenous Approaches to Infection Prevention and Control |
0.5 |
Yes |
9/22/2025 |
|
JAMA Dermatology |
Indurated Plaque With Ulceration on the Dorsum of the Left Hand |
1 |
Yes |
11/9/2025 |
|
American Society of Anesthesiologists |
Infection Control and Prevention 2023 |
0 |
Yes |
3/26/2026 |
|
American Medical Association |
Information Blocking Regulations: What to Know and How to Comply |
0.75 |
Yes |
3/19/2027 |
|
AMA Journal of Ethics |
Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm |
1 |
Yes |
11/1/2025 |
|
JAMA Oncology |
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer |
1 |
Yes |
9/23/2025 |
|
JAMA Oncology |
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer |
1 |
Yes |
9/23/2025 |
|
JAMA Oncology |
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer - The FAST Multidisciplinary Group Consensus Statement |
1 |
Yes |
7/11/2027 |
|
American Medical Association |
Injection Safety for Infection Prevention in a Dialysis Setting |
0.75 |
Yes |
2/7/2026 |
|
Clinical Care Options, LLC |
Innovation Insight: How are Novel Agents Reshaping Schizophrenia's Landscape? |
1 |
No |
12/31/2025 |
|
Clinical Care Options, LLC |
Innovative Approaches for PTSD: Unraveling Pathophysiology and New Treatment Frontiers |
1 |
No |
12/31/2025 |
